Olfactory Function in Parkinson’s Disease 1. 2. 3. 4. 5.
Hoehn MM, Yahr MD, Parkinsonism. Onset, progression and mortality, Neurology, 1967;17:427–42.
Ansari KA, Johnson A, Olfactory function in patients with Parkinson's disease, J Chron Dis, 1975;28:493–7.
Ward CD, Hess WA, Calne DB, Olfactory impairment in Parkinson's disease, Neurology, 1983;33:943–6.
Hawkes CH, Shephard BC, Daniel SE, Olfactory dysfunction in Parkinson's disease, J Neurol Neurosurg Psychiatry, 1997;62:36–46.
Doty RL, Deems D, Steller S, Olfactory dysfunction in Parkinson's disease: A general deficit unrelated to neurologic signs, disease stage, or disease duration, Neurology, 1988;38:1237–44.
6. 7. 8. 9.
Haehner A, Boesveldt S, Berendse HW et al., Prevalence of smell loss in Parkinson´s disease – a multicenter study, Parkinsonism Relat Disord, 2009;15:490–94.
Stern MB, Doty RL, Dotti M, et al., Olfactory function in Parkinson's disease subtypes, Neurology, 1994;44:266–8.
Ramaker C, Marinus J, Stiggelbout AM, et al., Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease, Mov Disord, 2002;17:867–76.
Hummel T, In: Chase T, Bedard P (Eds), Focus on Medicine Vol. 14 – New developments in the drug therapy of Parkinson’s disease. Blackwell Science, Oxford, UK, 1999;47–53.
10. Tissingh G, Berendse HW, Bergmans P, et al., Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis, Mov Disord, 2001;16:41–6.
11. Herting B, Scholz S, Haehner A, et al., A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease, J Neurol, 2008;255:367–70.
12. Müller A, Müngersdorf M, Reichmann H, et al., Olfactory function in Parkinsonian syndromes, J Clin Neurosci, 2002;9:521–4.
13. Müller A, Reichmann H, Livermore A, et al., Olfactory function in idiopathic Parkinson´s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow- up of de-novo IPD patients, J Neural Transm, 2002;109:805–11.
14. Tissingh G, Berendse HW, Bergmans P, et al., Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis, Mov Disord, 2001;16:41–6.
15. Ponsen MM, Stoffers D, Booij J, et al., Idiopathic hyposmia as a preclinical sign of Parkinson's disease, Ann Neurol, 2004;56:173–81.
16. Ponsen MM, Stoffers D, Twisk JW, et al., Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study, Mov Disord, 2009;24:1060–65.
17. Haehner A, Hummel T, Hummel C, et al., Olfactory loss may be a first sign of idiopathic Parkinson’s disease, Mov Disord, 2007;22:839–42.
18. Sommer U, Hummel T, Cormann K, et al., Detection of presymptomatic Parkinson’s disease: combination of olfactory tests, transcranial sonography, and 123 I-FP-CIT- SPECT, Mov Disord, 2004;19:1196–1202.
19. Marras C, Goldman S, Smith A, Smell identification ability in twin pairs discordant for Parkinson´s disease, Mov Disord, 2005;20:687–93.
20. Ross W, Petrovitch H, Abbott RD ,et al., Association of Olfactory Dysfunction with Risk for Future Parkinson’s Disease, Ann Neurol, 2008;63:167–73.
21. Hawkes C, The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?, Mov Disord, 2008,23:47–53.
22. Braak H, Del Tredici K, Rub U, et al., Staging of brain pathology related to sporadic Parkinson’s disease, Neurobiol Aging, 2003;24:197–211.
23. Huisman E, Uylings HB, Hoogland PV, A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease, Mov Disord, 2004;19: 687–92.
24. Huisman E, Uylings HB, Hoogland PV, Gender-Related Changes in Increase of Dopaminergic Neurons in the Olfactory Bulb of Parkinson’s Disease Patients, Mov Disord, 2008;23:1407–13.
25. Wenning GK, Shephard B, Hawkes C, et al., Olfactory function in atypical parkinsonian syndromes, Acta Neurol Scand, 1995;91:247–50.
26. Hummel T, Sekinger B, Wolf SR, et al., “Sniffin’ Sticks”: Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold, Chem Senses, 1997;22:39–52.
27. McKinnon JH, Demaerschalk BM, Caviness JN, et al., Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?, Neurologist, 2007;13:382–5.
28. Liberini P, Parola S, Spano PF, et al., Olfactory dysfunction in dementia associated with Lewy bodies, Parkinsonism Rel Disord, 1999;5:30.
29. Williams SS, Williams J, Combrinck M, et al., Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease, J Neurol Neurosurg Psychiatry, 2009;80:667–70.
30. Hawkes C, Olfaction in neurodegenerative disorder, Mov Disord, 2003;18:364–72.
31. Katzenschlager R, Lees AJ, Olfaction and Parkinson's syndromes: its role in differential diagnosis, Curr Opin Neurol, 2004;17:417–23.
32. Silveira-Moriyama L, Guedes LC, Kingsbury A, et al., Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data, Neurology, 2008;71:1021–6.
33. Doty RL, Singh A, Tetrud J, et al., Lack of major olfactory dysfunction in MPTP-induced parkinsonism, Ann Neurol, 1992;32:87–100.
34. Miwa T, Watanabe A, Mitsumoto Y, et al., Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, Acta Otolaryngol Suppl, 2004;553:80–84.
35. Krüger S, Haehner A, Thiem C, et al., Neuroleptic-induced parkinsonism is associated with olfactory dysfunction, J Neurol, 2008;255:1574–9.
36. Müller A, Reuner U, Landis B, et al., Extrapyramidal symptoms in Wilson`s disease are associated with olfactory dysfunction, Mov Disord, 2006;21:1311–16.
37. Witt M, Bormann K, Gudziol V, et al., Biopsies of olfactory epithelium in patients with Parkinson’s disease, Mov Disord, 2009;24:906–14.
38. Müller A, Abolmaali ND, Hakimi AR, et al., Olfactory bulb volumes in patients with Idiopathic Parkinson’s Disease – a pilot study, J Neural Transm, 2005;112:1363–70.
39. Scherfler C, Schocke M, Seppi K, et al., Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease, Brain, 2005;129:538–42.
40. Westermann B, Wattendorf E, Schwerdtfeger U, et al., Functional imaging of the cerebral olfactory system in patients with Parkinson’s disease, J Neurol Neurosurg Psychiatry, 2008;79:19–24.
41. Wattendorf E, Welge-Lüssen A, Fiedler K, et al., Olfactory impairment predicts brain atrophy in Parkinson´s disease, J Neuroscience, 2009;29:15410–13.
EUROPEAN NEUROLOGICAL REVIEW
29
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116